-
Vulvodynia Treatment Market 2027 – Status and Development, Average Product Price and Market Shares of Key Players
03 Nov 2022 07:53 GMT
Soaring cases of Vulvodynia is Projected to Drive Vulvodynia Treatment Market Growth
HYDERABAD, TELANGANA, INDIA, November 3, 2022 /EINPresswire.com/ -- Vulvodynia Treatment Market size is estimated to reach $77.4 billion by 2027, growing at a …
-
Gabapentin Market Significant Growth Prospects During 2019-2024 | Pfizer, Depomed, TEVA, Mylan, Arbor Pharma, Novartis, Apotex, Sun Pharmaceutical
24 Oct 2019 18:11 GMT
… covered in this report: Pfizer Depomed TEVA Mylan Arbor Pharma Novartis … presents a comprehensive overview, market shares, and growth opportunities of Gabapentin …
-
Assertio Therapeutics Inc (ASRT) Director, President and CEO Arthur J Higgins Bought $77,000 of Shares
13 Aug 2019 02:21 GMT
… (insider trades) bought 50,000 shares of ASRT on 08… this purchase was $77,000.
Depomed Inc is a specialty pharmaceutical … of $97.900 million; its shares were traded at around $1 … A. Peisert bought 19,000 shares of ASRT stock on 08 …
-
Depomed: 2Q Earnings Snapshot
08 Aug 2018 13:39 GMT
NEWARK, Calif. (AP) _ Depomed Inc. (DEPO) on Wednesday reported … expected $63.6 million.
Advertisement
Depomed shares have increased 16 percent since …
-
Depomed Announces Second-Quarter 2018 Financial Results
08 Aug 2018 11:30 GMT
… the live call.
About Depomed
Depomed is a leading specialty pharmaceutical … 63,611
62,331
Dilued shares used in calculation
63,719 … 28,030
$
12,577
Shares used in calculation (7)
82 … .86
)
Conversion from basic shares to diluted shares
0.07
…
-
Why Depomed Inc.'s Shares Soared 23.2% Higher
11 May 2018 13:06 GMT
… its full-year guidance, shares of Depomed Inc. (NASDAQ:DEPO) … fee. After four years, Depomed will receive double-digit … respectively, in Q1.
Additionally, Depomed improved its net loss guidance … Nucynta to Collegium provides Depomed with a predictable source …
-
Depomed Announces First-Quarter 2018 Financial Results
10 May 2018 12:00 GMT
… for three months.
About Depomed Depomed is a leading specialty …
$
(0.43
)
Basic shares used in calculation
63,503 …
62,129
Diluted shares used in calculation
81,877 …
(0.20
)
Adjustment of shares used in calculation
(0.06 …
-
Quotidian Technical Highlights on Selected Drug Makers Stocks -- Amarin, Apricus Biosciences, Depomed, and DURECT
25 Apr 2018 11:18 GMT
…
Depomed
At the close of trading on Tuesday, shares … in Newark, California headquartered Depomed Inc. … moving average. Moreover, shares of Depomed, which engages in the … stocks----amarin-apricus-biosciences-depomed-and-durect-300636190.html …
-
Depomed Announces Fourth Quarter and Full Year 2017 Financial Results
27 Feb 2018 21:03 GMT
… for three months.
About Depomed Depomed is a leading specialty … 63
)
$
(1.45
)
Shares used in calculating basic and … 756
$
56,993
Shares used in calculation (2)
… .45
)
Conversion from basic shares to diluted shares
0.12
…
-
Uptrend Call Working As Depomed Inc Stock Rises 25.6% (DEPO)
27 Jan 2018 10:53 GMT
…
SmarTrend identified an Uptrend for Depomed Inc (NASDAQ:DEPO) on … MA has declined 0.2%.
Depomed, Inc. develops new and … the incorporated drug or drugs. Depomed has also developed a system … the trajectory of Depomed Inc shares.Log in and add Depomed Inc (DEPO …
About
© 1995-2025